Biodiversity net gain
This POSTnote outlines the mandatory biodiversity net gain policy introduced in England in 2024 and the risks and challenges for delivering its objectives.
Documents to download
-
Plant-made Pharmaceuticals (210 KB , PDF)
The use of genetically modified (GM) plants to produce pharmaceutical drugs and vaccines is an emerging technology that offers a low-cost, large-scale alternative to current methods. This POSTnote looks at recent advances in, and the benefits of, the technology, and analyses the associated biosafety and regulatory issues.
Documents to download
-
Plant-made Pharmaceuticals (210 KB , PDF)
Related posts
-
-
Enhanced rock weathering: Potential UK greenhouse gas removal
This POSTnote outlines the benefits and challenges of using enhanced rock weathering as a GGR approach for addressing emissions from UK hard-to-abate sectors.
-
Automated vehicles
This POSTbrief explains what automated vehicles are and how they work. It outlines developments in the UK, benefits and concerns and policy considerations.
